OSTN contains two natriuretic peptide motifs, and is
expressed mainly in the bones and muscle. It is thought to
be an endogenous specific ligand for the clearance natriuretic
peptide receptor (NPR-C) and to modulate CNP levels by
blocking NPR-C activity.
